In addition to tPA's fibrinolytic activity, a number of non-fibrinolytic properties have been described for tPA, some of which predispose to HT, blood brain barrier (BBB) disruption, and neuronal injury [4-7]. This evidence concerns the gene PLAT and hematocrit.